Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis-Reference-Cited by-同舟云学术

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

Published:2020-09-17 Issue:12 Volume:383 Page:1117-1128
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Furie Richard¹,Rovin Brad H.¹,Houssiau Frédéric¹,Malvar Ana¹,Teng Y.K. Onno¹,Contreras Gabriel¹,Amoura Zahir¹,Yu Xueqing¹,Mok Chi-Chiu¹,Santiago Mittermayer B.¹,Saxena Amit¹,Green Yulia¹,Ji Beulah¹,Kleoudis Christi¹,Burriss Susan W.¹,Barnett Carly¹,Roth David A.¹

Affiliation:

1. From the Division of Rheumatology, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra–Northwell, Great Neck, NY (R.F.); the Division of Nephrology, Ohio State University, Columbus (B.H.R.); Pôle de Pathologies Rhumatismales Inflammatoires et Systémiques, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, and Service de Rhumatologie, Cliniques Universitaires Saint-Luc — both in Brussels (F.H.); Organización Médica de Investigación, Buenos Aires (A.M....

Funder

GSK

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2001180

Cited by 485 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The influence and therapeutic effect of microbiota in systemic lupus erythematosus;Microbiological Research;2024-04

2. Insights into future management of lupus nephritis;Frontiers in Lupus;2024-02-06

3. Emerging biologic therapies for systemic lupus erythematosus;Current Opinion in Rheumatology;2024-02-02

4. Kidney Biopsy in Management of Lupus Nephritis: A Case-Based Narrative Review;Kidney Medicine;2024-02

5. Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis;JCI Insight;2024-01-23